Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

March 25, 2020March 25, 2020

COVID-19 Patient with PH Treated with iNO Via Genosyl, VERO Biotech Announces

News, PH News

The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer ... Read more

March 20, 2020March 20, 2020

Orenitram Tablets More Cost-effective Than Uptravi as PAH Treatment, Study Suggests

News, PAH News

Treatment with Orenitram (oral treprostinil) is associated with lower healthcare-related costs than treatment with Uptravi (selexipag) in people with pulmonary arterial hypertension (PAH), a new study suggests. The study, “Medication Adherence ... Read more

March 18, 2020March 19, 2020

Major Bleed Risk Higher With Warfarin Than Xarelto in CTEPH Patients, Study Finds

CTEPH News, News

Among people with chronic thromboembolic pulmonary hypertension (CTEPH), certain anticoagulants may reduce the risk of serious bleeding more than others, a new study shows. The study, “Real-life data of ... Read more

March 13, 2020March 13, 2020

Bellerophon, FDA Agree on Design of Phase 3 INOPulse Clinical Trial

News, PH News

Bellerophon Therapeutics has reached an agreement with the U.S. Food and Drug Administration (FDA) setting the design of an upcoming, pivotal Phase 3 clinical trial testing INOpulse, an investigational ... Read more

February 24, 2020February 24, 2020

Using INOpulse Nitric Oxide Device Improves Blood Flow in Lungs in PH-PF, New Trial Data Suggest

News, PH News

Use of Bellerophon Therapeutics’ INOpulse device — which provides nitric oxide to the lungs — significantly improved parameters related to blood flow in the lungs in people with pulmonary ... Read more

February 17, 2020February 17, 2020

Case Report Suggests Lack of Vitamin C as PAH Cause

News, PAH News

Vitamin C deficiency can cause pulmonary arterial hypertension (PAH), a new case report suggests, highlighting the need to test vitamin C levels in people with PAH. The report, “Vitamin ... Read more

January 31, 2020January 31, 2020

Sotatercept Eases Heart Strain, Improves Exercise Capacity in PAH, Trial Shows

News, PAH News

Treatment with sotatercept (ACE-011) eased heart strain and improved exercise capacity in individuals with pulmonary arterial hypertension (PAH) participating in the Phase 2 PULSAR trial, according to Acceleron Pharma, the ... Read more

January 17, 2020January 17, 2020

Circular RNA Molecule May Help Diagnose, Predict Clinical Outcomes in IPAH, Study Suggests

News, PAH News

Levels of a circular RNA molecule in the blood could help diagnose and predict the clinical outcomes of those with idiopathic pulmonary arterial hypertension (IPAH), a study suggests. The ... Read more

January 3, 2020January 3, 2020

TriAxia Health Partners with Major Medical Centers to Build PAH Research Database

News, PAH News

TriAxia Health is partnering with three academic medical centers to build a large database aiming for a better understanding of rare pulmonary diseases, beginning with pulmonary arterial hypertension (PAH). ... Read more

Posts by: Marisa Wexler, MS

Marisa Wexler, MS

COVID-19 Patient with PH Treated with iNO Via Genosyl, VERO Biotech Announces

Orenitram Tablets More Cost-effective Than Uptravi as PAH Treatment, Study Suggests

Major Bleed Risk Higher With Warfarin Than Xarelto in CTEPH Patients, Study Finds

Bellerophon, FDA Agree on Design of Phase 3 INOPulse Clinical Trial

Using INOpulse Nitric Oxide Device Improves Blood Flow in Lungs in PH-PF, New Trial Data Suggest

Case Report Suggests Lack of Vitamin C as PAH Cause

Sotatercept Eases Heart Strain, Improves Exercise Capacity in PAH, Trial Shows

Circular RNA Molecule May Help Diagnose, Predict Clinical Outcomes in IPAH, Study Suggests

Top 10 Pulmonary Hypertension Stories of 2019

TriAxia Health Partners with Major Medical Centers to Build PAH Research Database

Pin It on Pinterest